Bill > HF2906

This bill establishes a comprehensive framework for a psilocybin therapeutic use program in Minnesota, designed to provide safe, regulated access to psilocybin for individuals 21 years and older with qualifying medical conditions. The program requires patients to undergo detailed health screenings and obtain certification from a healthcare practitioner, and mandates that psilocybin use be supervised by a registered facilitator during administration sessions. Patients can cultivate psilocybin for personal use or designate a cultivator, with strict rules about cultivation location and quantity. The bill creates robust protections for registered patients, designated cultivators, and facilitators, including safeguards against employment and housing discrimination. A Psychedelic Medicine Advisory Committee will be established to provide ongoing guidance, and the program emphasizes public education, harm reduction, and research into psilocybin's therapeutic potential. The bill also sets clear limitations on psilocybin use, such as prohibiting use in public places, schools, or while operating a motor vehicle, and establishes penalties for violations like selling or transferring psilocybin to non-registered individuals. The program is set to begin enrollment on January 1, 2027, with initial rulemaking and committee formation starting in 2025.

Health and Social Services

https://www.revisor.mn.gov/bills/bill.php?b=House&f=HF2906&ssn=0&y=2025